Answers are grounded in this paper and cite their sources.
The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2-infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.
No takes yet. Share an insight, caveat, or question.
Bussalino et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: